SPHK1 and renal cell adenocarcinoma: ABC294640, an SPHK2 selective inhibitor, downregulated the SK1 and SK2 mRNA expression in A498 kidney adenocarcinoma cells, and this initiated the decrease of S1P levels and increment of ceramide levels.